University of Southern California
USC Norris Comprehensive Cancer Center
If you are a patient, please contact Keck Medical Center of USC at 800-USC-CARE.

Trial 4P-09-14


Molecular Characterization of Circulating Tumor Cells in Prostate Cancer Patients.

Type: Other
Phase: Not Applicable
Status: Closed to Accrual with Ongoing Follow-up
Treatments:
Randomized: No
Defintions of terms and FAQ about clinical trials.
Trial Leaders/Researchers:  Mitchell Gross, M.D.
Other Trial Staff:  Vicky Araujo, D.M., Charlean Ketchens, R.N., Lagrimas Ilagan, D.M., Kristy Sartor Massopust, Coordinator, Honorina Enright, D.M., Yvette Viverette, R.N., Elysse Faye Ballon, Coordinator

Staff may log in to see study documents.


You may participate in this study if:
 Requirement
1Histologically confirmed prostate cancer
2At least 18 years of age
3No signs or symptoms of active infection
4Exhibits willingness to comply with the experimental procedures as outlined in this protocol
5Localized: Considered candidate for a radical prostatectomy
6Prostate cancer must be classified as intermediate or high risk based of the presence of any of the following factors: [a] Gleason score = / > 7; [b] Clinical stage = / > T2; [c] PSA = / > 10 ng/ml
7No prior use of systemic prostate cancer therapy such as androgen-deprivation therapy or cytotoxic chemotherapy
8Metastatic: Metastatic prostate cancer diagnosed by imaging and other clinical criteria
9Planned institution of systemic therapy (chemotherapy, hormonal therapy) for metastatic prostate cancer





For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or clinical.trials@med.usc.edu.

To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3111.